Targeting cuproptosis with nanomaterials for cancer immunotherapy.

Cancer immunotherapy has changed the landscape of tumor treatment. However, its efficacy is often limited by low response rates and drug resistance, especially in immunologically cold tumors. The recent discovery of cuproptosis, a distinct form of co…

Preview only. Read the full abstract at the source